Skip to main content

Home/ Groups/ OARS funding Cancer
MiamiOH OARS

Conquer Cancer Foundation Accepting Applications for Annual Career Development Award | ... - 0 views

  •  
    The Conquer Cancer Foundation was created by the American Society of Clinical Oncology to drive dramatic advances in the prevention, treatment, and cures of all types of cancer. CCF works to conquer cancer by funding breakthrough cancer research and sharing cutting-edge knowledge with patients and physicians worldwide, improving quality of and access to care, and enhancing quality of life for all who are touched by cancer.

MiamiOH OARS

Hirschberg Foundation Invites Applications for Pancreatic Cancer Research Grants | RFPs... - 0 views

  •  
    The annual program provides start-up funding to basic scientists and clinicians in a position to test innovative ideas for improving the diagnosis of and new treatment modalities for pancreatic cancer; obtain preliminary data required for additional funding from other agencies for pancreatic cancer research;  advance the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy; and establish collaborations within the field that can be considered for further funding. The foundation expects that seed grant awards will generate quality abstracts, papers, and presentations, as well as new proposals. Priority will be given to investigators whose primary intent is to build a strong curriculum in pancreatic cancer research.

MiamiOH OARS

DoD Peer Reviewed Cancer, Horizon Award - 0 views

  •  
    The FY18 PRCRP Horizon Award supports junior-level scientists in conducting impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor). The Horizon Award challenges junior scientists to develop and implement research in the cancer field. This opportunity allows for junior investigators to develop a research project, investigate a problem or question in the field of cancer, and further their intellectual development as a cancer researcher of the future.
MiamiOH OARS

National Foundation for Cancer Research Issues Call for Nominations for 2019 ... - 0 views

  •  
    The annual prize, named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, is awarded to an outstanding researcher whose scientific achievements have expanded our understanding of cancer and whose discoveries have made possible new approaches to the prevention, diagnosis, and/or treatment of cancer.

MiamiOH OARS

Administrative Supplements to Promote Collaborative Activities in Basic Cancer Research... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to incentivize collaborative, multidisciplinary research across a broad area of challenging topics in basic cancer biology. These supplement applications must propose a collaboration between at least two researchers, one being the PI of the parent NCI grant. Awarded supplements will leverage and extend currently funded cancer research in the parent grant.
MiamiOH OARS

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative ... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials. The scientific goals of this FOA are to: (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods, (b) implement the optimized methods in the co-clinical trial, and finally (c) populate a web-accessible research resource with all the data, methods, workflow documentation, and results collected from the co-clinical investigations. Co-clinical trials are defined in this FOA as investigations in patients and in parallel (or sequentially) in mouse or human-in-mouse models of cancer that mirror the genetics and biology of the patients malignancies or pre-cancerous lesions. The co-clinical trial should include either (a) a therapeutic goal, such as the prediction, staging, and/or measurement of tumor response to therapies, or (b) a screening and early detection or a cancer risk stratification goal for lethal cancer versus non-lethal disease. Applicants are encouraged to organize multi-disciplinary teams with experience in mouse models research, human investigations, imaging platforms, QI methods, decision support software and informatics to populate the research resource.
MiamiOH OARS

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical... - 0 views

  •  
    The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide-ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component.
MiamiOH OARS

PA-18-842: Administrative Supplements to Support Cancer Disparity Collaborative Researc... - 0 views

  •  
    The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component.
MiamiOH OARS

PAR-18-841: Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Q... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement applications to develop research resources that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve the quality of imaging results for co-clinical trials.



    The scientific goals of this FOA are to:

    (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods,

    (b) implement the optimized methods in the co-clinical trial, and finally

    (c) populate a web-accessible research resource with all the data, methods, workflow documentation, and results collected from the co-clinical investigation
MiamiOH OARS

Lymphoma Research Foundation Accepting Applications for Career Development Award | RFPs... - 0 views

  •  
    To advance this mission, the foundation is accepting applications for its LRF Clinical Investigator Career Development Award program, which is designed to support physician-investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools. The goal of the program is to prepare physician-investigators to design and administer clinical research studies in lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission, and publication.

MiamiOH OARS

Prostate Cancer, Health Disparity Fellowship Award - 0 views

  •  
    Research Approach: Proposed research ideas are required to address one or more of the FY18 PCRP Overarching Challenges. The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem presented and should focus on reducing and ultimately eliminating disparities in prostate cancer incidence, morbidity, and mortality. The proposal must explicitly state how the proposed research is related to a health disparity area within an affected population or community. The PCRP is interested in research that addresses all different aspects that contribute to health disparity in prostate cancer, including, but not limited to, social, cultural, and/or biological contributors. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how the proposed goals of the project can be achieved. The inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the PI, Mentor(s), or member(s) of the collaborating team. Additionally, required resources should be identified and supported through documentation.
MiamiOH OARS

Gilead Sciences Invites Applications for Research Scholars Program in Hematology/Oncolo... - 0 views

  •  
    To that end, grants of up to $130,000 over two years will be awarded to junior faculty researchers for innovative translational research projects in hematology/oncology (with a focus on hematologic malignancies) that can be either based around a clinical trial with strong correlative science or laboratory investigation.

MiamiOH OARS

Pardee Foundation Invites Proposals for Cancer Research Projects | RFPs | PND - 0 views

  •  
    To be eligible, principal investigators and co-PIs must have an earned doctorate in an academic discipline or professional field, or appropriate experience in an education research-related profession. In addition, the PI must be affiliated with a college, university, school district, nonprofit research facility, or nonprofit cultural institution that is willing to serve as the administering organization if the grant is awarded. The foundation does not award grants directly to individuals.
MiamiOH OARS

AGA Foundation Invites Applications for Funderburg Research Award in Gastric Cancer | R... - 0 views

  •  
    A single two-year grant of up to $100,000 will be awarded to an established investigator working on a novel approach in gastric cancer research, including the fields of gastric mucosal cell biology, regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair), inflammation (including Helicobacter pylori) as precancerous lesions, genetics of gastric carcinoma, oncogenes in gastric epithelial malignancies, epidemiology of gastric cancer, etiology of gastric epithelial malignancies, or clinical research in the diagnosis or treatment of gastric carcinoma.

MiamiOH OARS

RFA-CA-18-025: Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed) - 0 views

  •  
     The purpose of this Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to support the Cooperative Human Tissue Network (CHTN). The goal for CHTN is to collect and distribute to investigators high quality human tissue specimens to facilitate basic and early translational cancer research. For example, such specimens may be needed for scientific discovery and the development of various molecular diagnostic tests, prognostic or predictive assays. The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators' requests. Samples to be collected from patients include pre-cancerous, cancerous, and benign neoplastic tissues, as well as specimens corresponding to non-neoplastic diseases and uninvolved tissues.

MiamiOH OARS

PA-18-818: Administrative Supplements for Validation Studies of Analytical Methods for ... - 0 views

  •  
    The reproducibility and comparability of research on dietary supplements is enhanced by rigorous analytical characterization of key experimental materials and the publication of validated analytical methods that accurately and precisely characterized and quantify constituents in dietary supplement ingredients and products. This FOA builds on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of quantitative analytical methods. The methods proposed for validation must be used to identify and quantify dietary supplement-relevant chemical constituents (i.e., active or marker chemical compounds, adulterants, contaminants) or their metabolites in experimental reagents, raw materials, and/or clinical specimens (e.g., urine or plasma samples). Methods must have been developed or utilized in fulfillment of the active parent grant's specific aims. Candidate constituents for quantitative method validation studies include (but are not limited to): phytochemicals, nutrients, and potentially deleterious substances such as pesticides and mycotoxins. Multi-laboratory validation studies will not be supported through this FOA.
MiamiOH OARS

NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (U... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) solicits applications from institutions/organizations to participate as "Minority/Underserved Community Sites" for the National Cancer Institute (NCI)-supported Community Oncology Research Program (NCORP). NCORP is a community-based research network that: Designs and conducts clinical trials and other human subject studies for adults and children in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials; Incorporates the needs of diverse populations such as, adolescents and young adults (AYAs), and the elderly; racial and ethnic minorities; sexual and gender minorities; and rural residents into studies and takes steps to enhance participation of these groups; Enhances patient and provider access to treatment and imaging trials conducted under the National Clinical Trials Network (NCTN); Integrates cancer disparities research within the community network. NCORP consists of three components each with its own FOA: NCORP Research Bases; NCORP Community Sites; and NCORP Minority/Underserved Community Sites (covered by this FOA). The NCORP Minority/Underserved Community Sites will accrue diverse patients/participants to NCI-approved, cancer control, prevention, and care delivery research studies designed by NCI's NCORP Research Bases as well as treatment trials within the National Clinical Trials Network Groups (NCTN).
MiamiOH OARS

American Gastroenterological Association - 0 views

  •  
    Sponsored by the R. Robert and Sally D. Funderburg Charitable Trust, the annual award is designed to support an established investigator in the field of gastric biology whose research enhances our understanding of gastric cancer pathobiology and leads to its prevention or the development of a cure for the disease. The recipient will be selected based on novelty, feasibility, and significance of his/her proposal.
MiamiOH OARS

PA-18-821: Collaborative Activities to Promote Cancer Cachexia Research (Admin Supp - C... - 0 views

  •  
    The purpose of the Administrative Supplements for Collaborative Activities to Promote Cachexia Research is to support collaborative, multidisciplinary basic and translational research that addresses an important question in cancer cachexia and to expand the cadre of investigators experienced in cancer cachexia study design, model systems and data interpretation. These supplement applications must propose a collaboration between cancer researchers and researchers with documented expertise in cachexia research. The parent grant for the supplement must have an NCI primary assignment. Overall, the long-term goal of this supplement program is to encourage a focused examination of the biology of cancer cachexia and its effect on organs and systems beyond the tumor site(s).
MiamiOH OARS

DoD Kidney Cancer, Translational Research Partnership Award - 0 views

  •  
    The FY18 KCRP Translational Research Partnership Award mechanism supports partnerships between clinicians and research scientists that will accelerate the movement of promising ideas in kidney cancer toward clinical applications. This award supports the development of translational research collaborations between two independent, faculty-level (or equivalent) investigators to address a central problem or question in kidney cancer in a manner that would be less readily achievable through separate efforts. One partner in the collaboration must be a research scientist and the other must be a clinician. It should be clear that both have had equal intellectual input in the design of the research project. Multi-institutional partnerships are encouraged. At least one member of the partnership must have experience either in kidney cancer research or kidney cancer patient care. Inclusion of experts from outside the kidney cancer field is encouraged. A proposed project in which the clinical partner merely supplies tissue samples or access to patients will not meet the intent of this award mechanism.
1 - 20 of 566 Next › Last »
Showing 20 items per page